Local Comparator & Sequencing Adaptation
We help teams align global evidence with local comparator logic, sequencing reality, and subgroup-specific treatment practice.
What you get
Country comparator map
Market-by-market comparator landscape with treatment sequence context
Subgroup comparator matrix
Line-of-therapy and biomarker-specific comparator splits
Sequencing logic summary
Treatment pathway analysis with decision-point documentation
Country-level mapping
Map the relevant comparator, treatment sequence, and subgroup logic for each target market — country by country.
Sequencing logic rebuild
Identify where the global argument breaks and construct an adapted narrative for local payer/HTA evaluation.
Affiliate-ready outputs
Deliver country-ready decks, objection handlers, and evidence messages that match what local decision-makers evaluate.
About this service
Align global evidence with local comparator reality
Global clinical programs typically use one or two comparators. But local payers, HTA bodies, and treatment guidelines often reference a different comparator — or an entirely different treatment sequence.
We map comparator logic country by country, identify where the global evidence narrative breaks, and rebuild the argument using the comparator and sequencing reality of each target market.
The result: your Medical, Access, and Brand teams go into local conversations with an evidence story that matches what the decision-maker actually evaluates against.
Deliverables
What you get
Country comparator map
Market-by-market comparator landscape with treatment sequence context
Subgroup comparator matrix
Line-of-therapy and biomarker-specific comparator splits
Sequencing logic summary
Treatment pathway analysis with decision-point documentation
Comparator gap memo
Documented mismatch analysis between global narrative and local reality
HTA/payer objection matrix
Anticipated objections with evidence-backed response strategies
Country-ready messages
Evidence messages adapted for local field teams and payer conversations
How we work
Five phases to a local-ready argument
01
Review global evidence
Audit the global evidence package and the intended comparator narrative.
02
Map local comparators
Identify the relevant comparator, sequences, and subgroup splits for each market.
03
Identify gaps
Pinpoint where the global argument breaks and document the specific mismatch.
04
Build narrative
Construct a comparator story and objection layer that works for local payers/HTA.
05
Deliver outputs
Translate into country-ready decks, memos, and evidence messages for field teams.
AI-enabled workflow
AI-accelerated with expert oversight
AI scans literature and HTA databases for comparator signals. Medical and access experts validate the logic and build the local narrative.
What AI does
- PubMed/Web literature triage for comparator signals
- HTA decision database scanning across markets
- Draft structuring of comparator maps and matrices
- Slide deck prototyping for affiliate outputs
What MAG experts do
- Validate comparator logic against clinical reality
- Build the strategic narrative and objection layer
- Cross-check with local KOL/expert input
- Final quality control and MLR readiness review
Evidence Scanner™ modules used
PubMed/Web Monitoring
Fact-Checker
Slide Deck Prototyping
Literature Triage
Proof
How this service works in practice
Country-level evidence adaptation for 8 CEE affiliates — one core brief, 8 locally adapted versions with local comparators
Result:All 8 markets launched within the same quarter
Oncology
Read case →
Type 1 Diabetes clinical guidelines: international guidance adapted to local access, payer rules, and contextual realities
Result:Adopted as internal reference across priority markets
Endocrinology
Read case →
Payer objection handling matrix for CDK4/6 inhibitor: country-specific HTA responses across CEE markets
Result:Objection-response pairs used in 4 successful reimbursement submissions
Oncology
Read case →
Solves these challenges
Related problems
Comparator mismatch across countries and subgroups
Global evidence uses Comparator A, but the local payer/HTA evaluates against a different comparator.
See how we solve it →
Global evidence is not local-market ready
HQ sent a 200-slide deck. Affiliates need a 12-slide country brief adapted to local comparators.
See how we solve it →
The payer challenges the pathway, not the efficacy
Your clinical data is solid, but the payer objects to the treatment position and comparator relevance.
See how we solve it →
Frequently asked
Common questions
Is this only for Market Access?
No. Comparator logic directly affects Medical, regional teams, and sometimes Brand. When the comparator doesn’t match local reality, it impacts everyone who communicates about the product.
Do we always need local data?
Not always. Sometimes comparator remapping and subgroup logic restructuring is enough to bridge the gap. In other cases, local evidence generation is needed. We assess this during scoping.
Is this mainly an oncology issue?
No. Comparator mismatch is especially visible in oncology, but it’s also common in rare disease and specialty care — anywhere the standard of care varies significantly by market.
Can you work across multiple markets at once?
Yes. We routinely handle 5–12 market comparator adaptations simultaneously using a shared framework. This ensures consistency while reflecting local specifics.
How long does a comparator adaptation take?
3–8 weeks per market depending on complexity. Multi-market projects run in parallel from a shared core.
Need help with comparator adaptation?
Book a 20-minute scoping call. We’ll review your comparator situation and suggest the fastest path forward.
Book a scoping call →
Browse all services
Strong global data, weak local argument?
We help teams rebuild the argument where it matters most: country, subgroup, and decision context.
AI infrastructure
AI-powered.
Expert-validated.
We built AI workflows into our daily practice — not as a marketing claim, but as the infrastructure that lets our medical experts deliver faster without cutting corners.
Research
Structured PubMed queries with narrative or table outputs
Monitoring
Weekly literature digests by drug, target, or topic
AI-Enhanced EDC
Electronic data capture with AI-assisted quality checks
Fact-Checker
Claim verification against your source documents
AI accelerates. Our experts validate.
Every output goes through expert medical review before it reaches your team. AI handles structure and speed — we handle scientific judgement and MLR readiness.
// Comparator landscape scan
search("ribociclib_comparator_map.json", {
mode: "local_comparator_scan",
markets: 8,
output: "comparator_matrix + gap_memo",
})
Scanning comparator data across 8 EMEA markets...
Comparator Matrix
8 markets mapped. 3 use different first-line comparator. Subgroup splits in 5/8 markets. 2 markets require sequencing logic rebuild. Objection patterns: 6 recurring payer challenges identified...